These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32162361)
1. Pyoderma gangrenosum associated with ulcerative colitis: A recalcitrant case responded to adalimumab with granulocyte and monocyte adsorption apheresis. Isami Y; Kawase Y; Kondo A; Akita W; Yasuda K; Matsutani T; Mitsui H J Dermatol; 2020 May; 47(5):e213-e215. PubMed ID: 32162361 [No Abstract] [Full Text] [Related]
2. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis. Kawakami T; Yamazaki M; Soma Y Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102 [No Abstract] [Full Text] [Related]
3. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids. Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081 [TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Russo I; Miotto S; Colpo A; Marson P; Tison T; Ferrazzi A; Alaibac M Int Wound J; 2017 Feb; 14(1):282-284. PubMed ID: 27790848 [TBL] [Abstract][Full Text] [Related]
5. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis. Rodríguez-Lago I; Sempere L; Gutiérrez A; Núñez A; Leo Carnerero E; Hinojosa E; Mora M; Cañete F; Mañosa M; Herrera C; Beltrán B; Forés A; Arjona D; Barreiro-de Acosta M; Khorrami S; Aguirre U; Ginard D; Cabriada JL Scand J Gastroenterol; 2019 Apr; 54(4):459-464. PubMed ID: 30982369 [No Abstract] [Full Text] [Related]
6. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum. Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte apheresis for pouchitis with arthritis and pyoderma gangrenosum after restorative proctocolectomy for ulcerative colitis: a case report. Yanaru-Fujisawa R; Matsumoto T; Nakamura S; Kochi S; Iida M; Kohda F; Hirahashi M; Yao T; Mibu R Inflamm Bowel Dis; 2005 Aug; 11(8):780-1. PubMed ID: 16043996 [No Abstract] [Full Text] [Related]
8. Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis. Ikeda K; Hamada T; Otsuka M; Iwatsuki K Eur J Dermatol; 2011; 21(5):804-5. PubMed ID: 21752760 [No Abstract] [Full Text] [Related]
9. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis. Kanekura T; Kawahara K; Maruyama I; Kanzaki T Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369 [TBL] [Abstract][Full Text] [Related]